Status: current, Defined. Date: 31-Jan 2021. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 4012262016 | Product containing cedazuridine and decitabine (medicinal product) | en | Fully specified name | Active | Case insensitive | SNOMED CT core |
| 4012263014 | Cedazuridine- and decitabine-containing product | en | Synonym | Active | Case insensitive | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Cedazuridine- and decitabine-containing product | Is a | Hydrolase inhibitor-containing product | true | Inferred relationship | Some | ||
| Cedazuridine- and decitabine-containing product | Is a | Decitabine-containing product | true | Inferred relationship | Some | ||
| Cedazuridine- and decitabine-containing product | Has active ingredient | Decitabine | true | Inferred relationship | Some | 1 | |
| Cedazuridine- and decitabine-containing product | Has active ingredient | Cedazuridine | true | Inferred relationship | Some | 2 | |
| Cedazuridine- and decitabine-containing product | Plays role | Antineoplastic therapeutic role | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Cedazuridine and decitabine only product | Is a | True | Cedazuridine- and decitabine-containing product | Inferred relationship | Some | |
| Cedazuridine- and decitabine-containing product in oral dose form | Is a | True | Cedazuridine- and decitabine-containing product | Inferred relationship | Some |
This concept is not in any reference sets
FHIR